.jetcityimage/iStock Content by means of Getty Images Morgan Stanley has actually opted for Eli Lilly (NYSE: LLY) as its top biopharma selection for 2025 as well as ranked an additional 9 labels in the area as over weight. The financial investment bank mentioned in a keep in mind that it continues to strongly believe “diabesity is actually set to come to be.